Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Pardee

Showing results (111-120 of 243) with videos related to

Pageof 25
Sort By:
Biotechniques|May 1, 1995
New primer strategy improves precision of differential displayS Zhao, S L Ooi, A B Pardee
Nature Medicine|March 1, 1996
Cyclin E -- a better prognostic marker for breast cancer than cyclin D?Q P Dou, A B Pardee, K Keyomarsi
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Changes in the synthesis of actin and other cell proteins after stimulation of serum-arrested cellsV G Riddle, R Dubrow, A B Pardee
The Journal of Biological Chemistry|October 25, 1993
beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecinC J Li, L Averboukh, A B Pardee
Experimental Cell Research|October 15, 1979
Protein turnover and cell-cycle initiation in yeastB Shilo, V G Riddle, A B Pardee
Cancer Research|July 1, 1979
Different responses to drugs and serum of cells transformed by various meansR Dubrow, V G Riddle, A B Pardee
Journal of Cellular Physiology|April 1, 1987
Exposure to caffeine and suppression of DNA replication combine to stabilize the proteins and RNA required for premature mitotic eventsR Schlegel, R G Croy, A B Pardee
Cancer Research|October 1, 1996
Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell lineR S Alpan, M Zhang, A B Pardee
The Journal of Biological Chemistry|March 11, 1994
Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virusC J Li, C Wang, A B Pardee
Critical Reviews in Eukaryotic Gene Expression|January 29, 2000
Evolution of transcriptional control from prokaryotic beginnings to eukaryotic complexitiesL Huang, R J Guan, A B Pardee
Pageof 25

Showing results (111-120 of 243) with videos related to

Sort By:
Pageof 25
Biotechniques|May 1, 1995
New primer strategy improves precision of differential displayS Zhao, S L Ooi, A B Pardee
Nature Medicine|March 1, 1996
Cyclin E -- a better prognostic marker for breast cancer than cyclin D?Q P Dou, A B Pardee, K Keyomarsi
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Changes in the synthesis of actin and other cell proteins after stimulation of serum-arrested cellsV G Riddle, R Dubrow, A B Pardee
The Journal of Biological Chemistry|October 25, 1993
beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecinC J Li, L Averboukh, A B Pardee
Experimental Cell Research|October 15, 1979
Protein turnover and cell-cycle initiation in yeastB Shilo, V G Riddle, A B Pardee
Cancer Research|July 1, 1979
Different responses to drugs and serum of cells transformed by various meansR Dubrow, V G Riddle, A B Pardee
Journal of Cellular Physiology|April 1, 1987
Exposure to caffeine and suppression of DNA replication combine to stabilize the proteins and RNA required for premature mitotic eventsR Schlegel, R G Croy, A B Pardee
Cancer Research|October 1, 1996
Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell lineR S Alpan, M Zhang, A B Pardee
The Journal of Biological Chemistry|March 11, 1994
Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virusC J Li, C Wang, A B Pardee
Critical Reviews in Eukaryotic Gene Expression|January 29, 2000
Evolution of transcriptional control from prokaryotic beginnings to eukaryotic complexitiesL Huang, R J Guan, A B Pardee
Pageof 25